 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX  Get Free Report) rose 3.3% on Tuesday . The company traded as high as $25.21 and last traded at $25.00. Approximately 15,630 shares traded hands...

SpringWorks Therapeutics (NASDAQ:SWTX) Stock Price Up 3.3%

Bain Capital Life Sciences Investors LLC lowered its stake in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX  Free Report) by 36.2% during the first quarter, according to the company...

SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) Position Decreased by Bain Capital Life Sciences Investors LLC

STAMFORD, Conn., Sept. 11, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a clinical-stage biopharmaceutical company focused on developing life-changing medicines for...

SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer

This indicator may be signaling that SWTX's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

SpringWorks Therapeutics (SWTX, $27.04) entered Downtrend as Momentum indicator drops below 0 level on Sep 07, 2023

This is a Bearish indicator signaling SWTX's price could decline from here. Traders may explore shorting the stock or put options...

SpringWorks Therapeutics (SWTX, $27.04) Moving Average Convergence Divergence (MACD) Histogram turned negative on September 7, 2023

In trading on Wednesday, shares of SpringWorks Therapeutics Inc (SWTX) crossed below their 200 day moving average of 27.24, changing hands as low as 26.95 per share. SpringWorks...

SpringWorks Therapeutics Breaks Below 200-Day Moving Average - Notable for SWTX

This indicator may be signaling SWTX's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

SpringWorks Therapeutics (SWTX, $30.33) entered Uptrend as Momentum indicator ascends above 0 level on Sep 01, 2023

California State Teachers Retirement System lifted its position in shares of SpringWorks Therapeutics, Inc. (NASDAQ:SWTX  Free Report) by 14.6% during the first quarter, according to the...

California State Teachers Retirement System Increases Holdings in SpringWorks Therapeutics, Inc. (NASDAQ:SWTX)

SpringWorks Therapeutics (SWTX, $28.19) entered Downtrend as Momentum indicator drops below 0 level on Aug 31, 2023

SpringWorks Therapeutics (SWTX, $28.88) entered Uptrend as Momentum indicator ascends above 0 level on Aug 30, 2023

Springworks Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the application of a medicine approach to acquiring, developing, and commercializing medicines. Its pipeline includes Nirogacestat, Mirdametinib, BGB-3245 (RAF Fusion and Dimer Inhibitor), SW-682 (TEAD Inhibitor), and EGFR Inhibitor. The company was founded in August 2017 and is headquartered in Stamford, CT.

Watchers	543
52-Wk Low	$21.04
52-Wk High	$34.16

Market Cap	$1.43B
Volume (M)	596,078.00
52-Wk High	$34.16
52-Wk Low	$21.04

SWTX SpringWorks Therapeutics Inc

About

Feed

News

Sentiment

Earnings

Fundamentals